Bayer | BAYN - Assets


Bayer reported EUR113.47B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Air Liquide EUR 56.28B 4.36B Jun/2026
Akzo Nobel EUR 16.02B 114M Sep/2026
Alcon AG USD 31.1B 521M Jun/2026
Amarin USD 634.08M 9.72M Sep/2026
Arkema EUR 14.16B 11.4M Sep/2026
AstraZeneca USD 119.92B 4.09B Sep/2026
BASF EUR 79.94B 3.92B Sep/2026
Bayer EUR 113.47B 6.18B Sep/2026
Beiersdorf EUR 13.32B 560M Jun/2026
Corteva USD 41.64B 1.08B Jun/2026
Covestro EUR 13.88B 408M Jun/2026
Essilor EUR 65.06B 1.16B Jun/2026
Fresenius EUR 42.24B 401M Sep/2026
Fresenius Medical Care EUR 31.45B 155.97M Sep/2026
Genmab DKK 12.52B 139M Jun/2026
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
GRIFOLS EUR 20.28B 191M Sep/2026
Henkel EUR 36.5B 3.96B Jun/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Johnson Matthey GBP 5.97B 142M Jun/2026
Linde USD 88.08B 1.76B Sep/2026
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 52.69B 383M Jun/2026
Novartis USD 117.15B 4.88B Sep/2026
Nutrien USD 52.69B 862M Sep/2026
Philips EUR 28.03B 1.33B Sep/2026
PPG Industries USD 22.57B 40M Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 130.29B 1.23B Sep/2026
SAP EUR 76.34B 727M Sep/2026
Solvay EUR 6.22B 139M Sep/2026
UCB EUR 18.16B 971M Dec/2025
Umicore EUR 10.06B 603.5M Jun/2026
Vinci EUR 134.87B 1.8B Jun/2026